Literature DB >> 18243039

Protease-activated receptors in the musculoskeletal system.

E J Mackie1, L-H Loh, S Sivagurunathan, K Uaesoontrachoon, H-J Yoo, D Wong, S R Georgy, C N Pagel.   

Abstract

Protease-activated receptors (PARs) mediate cellular responses to a subset of extracellular proteases, including blood coagulation factors and proteases produced by inflammatory cells. Cells in bone, cartilage and muscle exhibit cell type-specific expression patterns and functional responses for the different PARs. Activators of PAR-1 include thrombin, and activators of PAR-2 include trypsin and tryptase; PARs-3 and -4 are also receptors for thrombin. Thrombin stimulates PAR-1-mediated proliferative responses in osteoblasts, chondrocytes and myoblasts, and in developing muscle, PAR-1 activation by thrombin appears to mediate activity-dependent polyneuronal synapse reduction. In bone, activation of PAR-2 leads to inhibition of osteoblast-mediated osteoclast differentiation induced by hormones or cytokines, and in muscle, PAR-2 activation leads to stimulation of myoblast proliferation. Although there is some evidence for a role for PARs expressed by cells of the musculoskeletal system at specific stages of development, their major role appears to be in protecting the tissues from the destructive effects of inflammation and promoting regeneration. This review discusses the regulation of cell function in the musculoskeletal system by receptor-mediated responses to proteases. Expression patterns of PARs, the circumstances in which PAR activators are likely to be present, functional responses of PAR activation, and responses to thrombin for which receptors have not yet been identified are considered.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18243039     DOI: 10.1016/j.biocel.2007.12.003

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  7 in total

1.  Protease-Activated Receptor 1 Deletion Causes Enhanced Osteoclastogenesis in Response to Inflammatory Signals through a Notch2-Dependent Mechanism.

Authors:  Sandra Jastrzebski; Judith Kalinowski; Sehwan Mun; Bongjin Shin; Naga Suresh Adapala; Christian E Jacome-Galarza; Faryal Mirza; H Leonardo Aguila; Hicham Drissi; Archana Sanjay; Ernesto Canalis; Sun-Kyeong Lee; Joseph A Lorenzo
Journal:  J Immunol       Date:  2019-05-20       Impact factor: 5.422

2.  Potent agonists of the protease activated receptor 2 (PAR2).

Authors:  Scott Boitano; Andrea N Flynn; Stephanie M Schulz; Justin Hoffman; Theodore J Price; Josef Vagner
Journal:  J Med Chem       Date:  2011-02-04       Impact factor: 7.446

3.  Effects of a systemic enzyme therapy in healthy active adults after exhaustive eccentric exercise: a randomised, two-stage, double-blinded, placebo-controlled trial.

Authors:  Tobias Marzin; Gerhard Lorkowski; Claudia Reule; Stefanie Rau; Elisabeth Pabst; Johannes C Vester; Helmut Pabst
Journal:  BMJ Open Sport Exerc Med       Date:  2017-03-12

4.  Osteogenesis in human periodontal ligament stem cell sheets is enhanced by the protease-activated receptor 1 (PAR1) in vivo.

Authors:  Tomaz Alves; Letícia M Gasparoni; Danilo Balzarini; Emmanuel Albuquerque-Souza; Victhor de Oliveira; Emanuel S Rovai; Jose da Silva; Aldrin Huamán-Mendoza; Luiz H Catalani; Carla R Sipert; Marinella Holzhausen
Journal:  Sci Rep       Date:  2022-09-18       Impact factor: 4.996

5.  Matriptase Induction of Metalloproteinase-Dependent Aggrecanolysis In Vitro and In Vivo: Promotion of Osteoarthritic Cartilage Damage by Multiple Mechanisms.

Authors:  David J Wilkinson; Hui Wang; Angela Habgood; Heather K Lamb; Paul Thompson; Alastair R Hawkins; Antoine Désilets; Richard Leduc; Torsten Steinmetzer; Maya Hammami; Melody S Lee; Charles S Craik; Sharon Watson; Hua Lin; Jennifer M Milner; Andrew D Rowan
Journal:  Arthritis Rheumatol       Date:  2017-07-05       Impact factor: 15.483

6.  In vivo fluorescence molecular tomography of induced haemarthrosis in haemophilic mice: link between bleeding characteristics and development of bone pathology.

Authors:  K K Vøls; M Kjelgaard-Hansen; C D Ley; A K Hansen; M Petersen
Journal:  BMC Musculoskelet Disord       Date:  2020-04-14       Impact factor: 2.362

7.  Deletion of Coagulation Factor IX Compromises Bone Mass and Strength: Murine Model of Hemophilia B (Christmas Disease).

Authors:  Emily A Larson; Hillary J Larson; Jason A Taylor; Robert F Klein
Journal:  Calcif Tissue Int       Date:  2021-06-12       Impact factor: 4.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.